NEOS THERAPEUTICS INC's ticker is NEOS and the CUSIP is 64052L106. A total of 52 filers reported holding NEOS THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $26,000 | +100.0% | 41,401 | +71.1% | 0.00% | +50.0% |
| Q3 2020 | $13,000 | -69.0% | 24,197 | -13.0% | 0.00% | -50.0% |
| Q4 2019 | $42,000 | +68.0% | 27,813 | +41.1% | 0.00% | +300.0% |
| Q2 2019 | $25,000 | -80.9% | 19,705 | -60.9% | 0.00% | -85.7% |
| Q1 2019 | $131,000 | -27.6% | 50,422 | +131.5% | 0.01% | -30.0% |
| Q1 2018 | $181,000 | -32.5% | 21,779 | -17.1% | 0.01% | -28.6% |
| Q4 2017 | $268,000 | – | 26,259 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DSC Advisors, L.P. | 1,043,770 | $7,620,000 | 2.51% |
| Stonepine Capital Management, LLC | 565,100 | $4,125,000 | 2.23% |
| DAFNA Capital Management LLC | 209,873 | $1,532,000 | 1.09% |
| Ghost Tree Capital, LLC | 500,000 | $3,650,000 | 0.76% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,459,195 | $10,652,000 | 0.57% |
| PURA VIDA INVESTMENTS, LLC | 150,000 | $1,095,000 | 0.44% |
| J. Goldman & Co LP | 845,000 | $6,169,000 | 0.33% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 191,729 | $1,400,000 | 0.20% |
| Opaleye Management Inc. | 50,000 | $365,000 | 0.15% |
| HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC | 50,000 | $365,000 | 0.15% |